Ryner Lai

| A patient with microscopic polyangiitis (MPA)—a form of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV)—was

The early administration of rituximab therapy is recommended as an initial treatment approach in patients with untreated advanced-stage follicular lymphoma (FL) with a low tumor burden, according to a presentation at the ASH Annual Meeting 2024.

| The proportion of patients with microscopic polyangiitis (MPA) with interstitial lung disease (ILD) is significant enough for antineutrophil

Beyond the clinical processes of diagnosis, management, and multidisciplinary coordination, there has been an increased awareness regarding the

| A patient with preexisting hereditary angioedema (HAE) experienced worsening attacks during her pregnancy and required anticoagulant therapy for venous thrombosis during the postpartum period.

Betibeglogene autotemcel (beti-cel) gene therapy is effective in allowing some patients with severe forms of transfusion-dependent beta-thalassemia (TDT) to achieve near-normal levels of hemoglobin and attain transfusion independence, according to a study published in The Lancet.

Myelofibrosis (MF) is a myeloproliferative neoplasm in which prognosis for long-term survival is notably poor.

A severe anaphylactic reaction can be life-threatening, and once interventions have been initiated to put the patient's life out of danger, it is

Continuous patient-facing medical education empowers patients to take responsibility for their own health and should therefore form the core of clinical consultations, especially in disease areas that are both rare and complex.

Immune tolerance induction (ITI) with recombinant factor VIII (FVIII) fusion protein (rFVIIIFc) show promise in the management of patients with difficult-to-treat inhibitor hemophilia A, according to a study published in Therapeutic Advances in Hematology.